NOC vs XOMAP · P/E 17, rev $20.76B vs P/E 25, rev $28.5M
Northrop Grumman Corporation (NOC) versus XOMA Royalty Corporation (XOMAP) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
Not investment advice. Open the NOC and XOMAP stock pages for the full models.
Not investment advice.